Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Eleventh Circuit to Decide if University May Grow Marijuana for Research Purposes
Professor Lyle Craker of the University of Massachusetts-Amherst Department of Plant, Soil and Insect Sciences has appealed a Drug Enforcement Administration (DEA) decision denying his bid to grow marijuana for medical research. Currently, the only facility in the United States legally authorized to grow marijuana for such purposes is located at the University of Mississippi. The U.S. Court of Appeals for the First Circuit heard oral arguments in May. The case, Craker v. DEA, began with Craker's written request to the DEA for a license to grow marijuana because “[a] second source of plant material is needed to facilitate privately funded, FDA-approved research into medical uses of marijuana, ensuring a choice of sources and an adequate supply of quality, research-grade marijuana for medicinal applications.” In its 2009 denial order, DEA administrator Michele Leonhart wrote that Craker's proposed registration was inconsistent with the United States' obligations under the U.N. Single Convention on Narcotic Drugs, because that convention requires a monopoly on the wholesale distribution of research-grade marijuana in the United States. Leonhart's order also explained that Craker had failed to make a showing that the supply of medical-grade marijuana from the University of Mississippi was inadequate for U.S. research purposes.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.
Each stage of an attorney's career offers opportunities for a curriculum that addresses both the individual's and the firm's need to drive success.
A defendant in a patent infringement suit may, during discovery and prior to a <i>Markman</i> hearing, compel the plaintiff to produce claim charts, claim constructions, and element-by-element infringement analyses.